Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma - A multicenter Phase II study of the Southern Italy Cooperative Oncology Group / Daponte, A; Ascierto, P; Gravina, A; Melucci, Mt; Palmieri, G; Comella, P; Cellerino, R; Delena, M; Marini, G; Comella, G. - In: CANCER. - ISSN 0008-543X. - 89:12(2000), pp. 2630-2636. [10.1002/1097-0142(20001215)89:12<2630::AID-CNCR16>3.0.CO;2-Z]
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma - A multicenter Phase II study of the Southern Italy Cooperative Oncology Group
Ascierto P;
2000
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
